Rui Avelar
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Evolus, Inc. (EOLS)
Source not stated
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $545,400 | $1,699,084 |
| 2024 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $515,725 | $2,884,613 |
| 2023 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $487,750 | $2,929,178 |
| 2022 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $469,000 | $1,264,912 |
| 2021 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $445,000 | $1,242,377 |
| 2020 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $403,333 | $1,313,906 |
| 2019 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $400,000 | $1,836,610 |
| 2018 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research and Development | $367,885 | $3,156,325 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.